EU Approves First Biologic for Severe Uncontrolled Asthma
Tezspire is the first and only biologic approved in the EU for patients with severe asthma with no phenotype or biomarker limitations.
United States Department Of Respiratory Medicine Ghent University Hospital European Commission Guy Brusselle Respiratory Medicine
Source: medscape.com